Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
Appointed director

Assure Holdings Corp. (IONM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/15/2023 8-K Quarterly results
Docs: "Key Financial Highlights 2Q 2023 2Q 2022 YTD through Q2 2023 YTD through Q2 2022 Gross Revenue $ 4,006 $ 9,209 $ 8,796 $ 18,345 Accounts Receivable Reserve Revenue, net 1,543 1,645 5,095 6,346 Gross margin Total Operating Expenses 3,605 4,094 7,128 8,845 Net loss Adjusted EBITDA* *See Explanation of Non-GAAP Financial Measures below for an explanation of Adjusted EBITDA and a reconciliation to GAAP financial measures Management Commentary “Our second quarter results reflect the continued and constant downward pressure on reimbursement from insurance payors,” said Chief Executive Officer, John Farlinger. “We had optimistic expectations that the federal IDR process that started last year would help assist Assure and the entire healthcare industry to negotiate for equitable reimbursem..."
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Acquisition/merger/asset purchase announced
Docs: "ASSET PURCHASE AGREEMENT",
"NOMINEE AGREEMENT",
"Company” or “Assure"
07/28/2023 8-K Quarterly results
06/29/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Letter of Intent with Innovation"
05/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ASSURE HOLDINGS CORP. ANNOUNCES CLOSING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING DENVER, COLORADO, May 16, 2023 -- Assure Holdings Corp. , a provider of intraoperative neuromonitoring and remote neurology services, today announced the closing of an underwritten public offering of 5,000,000 shares of its common stock at an offering price to the public of $1.20 per share . The pre-funded warrants are immediately exercisable at a nominal exercise price of $0.001 or on a cashless basis and may be exercised at any time until all of the pre-funded warrants are exercised in full. Joseph Gunnar & Co., LLC acted as the sole book-running manager for the offering. The gross proceeds to the Company from the offering are approximately $6 million, before deducting the underwriters’ fees and other offe..."
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/12/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ASSURE HOLDINGS CORP. ANNOUNCES PRICING OF $6 MILLION UNDERWRITTEN PUBLIC OFFERING DENVER, COLORADO, May 12, 2023 -- Assure Holdings Corp. , a provider of intraoperative neuromonitoring and remote neurology services, today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at an offering price to the public of $1.20 per share . The pre-funded warrants will be immediately exercisable at a nominal exercise price of $0.001 or on a cashless basis and may be exercised at any time until all of the pre-funded warrants are exercised in full. The closing of the offering is expected to occur on or about May 16, 2023, subject to the satisfaction of customary closing conditions. Joseph Gunnar & Co., LLC is acting as the sole book-running manager for the of..."
05/12/2023 POS EX Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
05/12/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
05/12/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/10/2023 8-K Quarterly results
Docs: "Key Financial Highlights 1Q'23 1Q'22 Gross Revenue $ 4,790 $ 9,136 Accounts Receivable Reserve Revenue, net 3,552 4,701 Gross margin 179 824 Total Operating Expenses 3,523 4,751 Net loss Adjusted EBITDA Management Commentary “First quarter 2023 cash receipts increased from the fourth quarter of 2022 and this strength has continued into the second quarter,” said John Farlinger, Assure’s executive chairman and CEO. “We collected approximately $4.5 million of cash and reduced our average days to collect the first payment on services rendered by 16 days in the first quarter. As a reminder, we experience seasonality during the first quarter each year as more of our volume is non-commercial, resulting in reduced revenue. During 2023, we have continued to experience weakness in reimbursement r..."
05/10/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/02/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/14/2023 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
04/14/2023 8-K Quarterly results
04/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2023 8-K Quarterly results
Docs: "Key Financial Metrics FY 2022 FY 2021 Gross Revenue $ 28,854 $ 36,583 Accounts Receivable Reserve Revenue, net 10,976 29,192 Gross margin 14,874 Total Operating Expenses 23,610 17,001 Net loss Adjusted EBITDA* 1,088 *See Explanation of Non-GAAP Financial Measures below for an explanation of Adjusted EBITDA and a reconciliation to GAAP financial measures Key Operational Metrics 4Q'22 4Q'21 FY 2022 FY 2021 Remote Neurology Managed Cases 2,200 600 11,000 2,100 Total Managed Cases 5,400 5,300 21,600 17,400 Full Year 2022 Financial Summary vs. Full Year 2021 ● Total revenue was $11.0 million versus $29.2 million ● Managed cases increased 24% to a record 21,600 versus 17,400 ● Total Assure cash receipts were $21.0 million in 2022 versus $13.4 million in 2021, an increase of 5..."
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2023 144 Form 144 - Report of proposed sale of securities:
02/14/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 4 Parsons Preston T (10% Owner) has filed a Form 4 on Assure Holdings Corp.
Txns: Sold 25,000 shares @ $0.29, valued at $7.3k
02/03/2023 4 Parsons Preston T (10% Owner) has filed a Form 4 on Assure Holdings Corp.
Txns: Sold 25,000 shares @ $0.2862, valued at $7.2k
01/30/2023 4 Parsons Preston T (10% Owner) has filed a Form 4 on Assure Holdings Corp.
Txns: Sold 14,000 shares @ $0.329, valued at $4.6k
Sold 8,000 shares @ $0.322, valued at $2.6k
01/27/2023 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
01/26/2023 4 Parsons Preston T (10% Owner) has filed a Form 4 on Assure Holdings Corp.
Txns: Sold 7,000 shares @ $0.34, valued at $2.4k
Sold 33,000 shares @ $0.34, valued at $11.2k
01/24/2023 4 Parsons Preston T (10% Owner) has filed a Form 4 on Assure Holdings Corp.
Txns: Sold 14,500 shares @ $0.3455, valued at $5k
01/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy